News | Cardiovascular Surgery | March 31, 2016

Minimally Invasive Mitral Valve Surgery Viable Option for Select Heart Patients

First multi-institutional study shows mini-MVR patients experienced shorter hospital stays, fewer blood transfusions

minimally invasive mitral valve repair, mini-MVR, comparison study, conventional surgery, University of Virginia

March 31, 2016 — Patients undergoing minimally invasive mitral valve repair or replacement (mini-MVR) have similar outcomes as patients undergoing conventional surgery, according to an article posted online by The Annals of Thoracic Surgery. Mini-MVR patients also experience shorter hospital stays and fewer blood transfusions.

MVR is a common treatment for mitral valve disease, including mitral stenosis (when the valve doesn’t allow enough blood flow) and mitral regurgitation (when blood leaks backwards out of the valve).

“Our research is the first multi-institutional study of patients undergoing mini-MVR as compared to traditional surgery,” said Emily A. Downs, M.D., from the University of Virginia in Charlottesville, who led the study. “We believe our results are important as they may facilitate further adoption of mini-MVR and provide patients with more options when faced with surgery.”

Downs, Gorav Ailawadi, M.D., and researchers from a statewide consortium of 18 hospitals in the Virginia Cardiac Surgery Quality Initiative examined records for 1,304 patients who underwent isolated MVR from 2011 to 2014. This included 425 (32.6 percent) who underwent mini-MVR.

During traditional MVR, a cardiothoracic surgeon makes a 6- to 8-inch-long incision down the center of the sternum (breastbone) to open the chest and provide direct access to the heart. In mini-MVR, the surgeon makes a 2- to 3-inch incision between the ribs on the right chest.

The researchers found that patients undergoing mini-MVR had similar rates of mortality, stroke (in contrast to previous research) and other complications compared with conventional MVR. They also found that mini-MVR patients experienced shorter intensive care unit and hospital lengths of stay, as well as fewer blood transfusions. Total hospital costs were similar between the two groups, despite previous assumptions by the researchers that mini-MVR might lead to higher costs.

“In our experience, mini-MVR is suitable for many patients and is particularly useful in both elderly patients with mobility issues and in young, healthy patients who desire quicker recovery and return to work,” said Ailawadi. “Patients who are not ideal candidates for mini-MVR include those with severe mitral annular calcification, right ventricular dysfunction or considerable aortic calcification.”

Adoption of mini-MVR has been slow; however, procedural volume is expected to increase as more results on outcomes and costs become available.

“Mini-MVR may not be appropriate for all centers, surgeons or patients; however, it should be an essential approach to consider in the armamentarium of an advanced mitral valve center,” said Ailawadi.

For more information: www.annalsthoracicsurgery.org

Related Content

CMS Awards New Technology Add-on Payment for Perceval Sutureless Aortic Heart Valve
News | Heart Valve Technology| August 22, 2017
August 22, 2017 — LivaNova PLC announced its Perceval ...
Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Overlay Init